A Chicken Model to Study Hepatitis E Virus Pathogenesis

研究戊型肝炎病毒发病机制的鸡模型

• 批准号: 7575805
• 负责人: XIANG-JIN MENG
• 金额: $ 31.7万
• 依托单位: VIRGINIA POLYTECHNIC INST AND ST UNIV
• 依托单位国家: 美国
• 财政年份: 2002
• 资助国家: 美国
• 起止时间: 2002-06-15 至 2012-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7575805
• 关键词: Address; Age; Amino Acids; Animal Experiments; Animal Model; Animals; Antibodies; Appearance; Attenuated; Avian Proteins; Award; Binding; Biochemical; Biological Models; Biology; Birds; C-terminal; Capsid; Capsid Proteins; Cell Culture System; Cell Culture Techniques; Chickens; Clinical; Cloning; Complementary DNA; Data; Developed Countries; Developing Countries; Disease; Farming environment; Functional RNA; Funding; Future; Genes; Genetic Determinism; Genomics; Genotype; Hepatitis E; Hepatitis E virus; Hepatocyte; Human; In Vitro; Infection; Kinetics; Knock-out; Knowledge; Laboratories; Lesion; Measures; Methods; Minor; Modeling; Molecular; Morphogenesis; Mutagenesis; Mutation; Nature; PXXP Motif; Pathogenesis; Pathogenicity; Phenotype; Pilot Projects; Pregnant Women; Preventive; Primates; Process; Production; Proline; Protein Biosynthesis; Proteins; Public Health; RNA chemical synthesis; Reagent; Research; Role; Route; Serological; Signal Transduction; Specific Pathogen Frees; Staging; Structural Protein; Techniques; United States; United States National Institutes of Health; Vaccines; Viral Pathogenesis; Viral Proteins; Viremia; Virion; Virus; Virus Diseases; Virus Replication; Work; attenuation; base; comparative; cost; design; egg; expression vector; germ free condition; in vivo; mortality; mutant; pathogen; protein expression; research study; tool; vaccine development; viral RNA; virus pathogenesis

DESCRIPTION (provided by applicant): Hepatitis E virus (HEV), the causative agent of human hepatitis E, is an important public health problem in many developing countries, and is also endemic in the United States and other industrialized countries. The mortality rate is reportedly up to 30% in infected pregnant women. Due to the lack of a practical animal model and a sufficient in vitro cell culture system, the mechanisms of HEV replication and pathogenesis are poorly understood and a vaccine for HEV is still not available. Supported by a 4-year R01 award, we have generated enormous amounts of important data including the construction of an infectious cDNA clone of an avian strain of HEV and establishment of a unique small homologous chicken model for HEV. Since we have completed all proposed work and since this 4-year R01 ended on June 14, 2006 (currently on a 1- year no-cost extension), we thus submit this twice-amended (A2) competing renewal to continue our long-term objectives on this important but extremely understudied human pathogen. The central hypothesis is that avian HEV and chickens is a useful model system to delineate the mechanisms of HEV replication and pathogenesis. The long-term objectives are to define the mechanisms of HEV replication and pathogenesis by using avian HEV and chickens as a model system and by using avian HEV infectious cDNA clone to identify HEV genes and genetic determinants that are functionally important for these processes. There are 3 specific aims in this twice-amended competing renewal: (1).Comparative pathogenesis between an apparently non- pathogenic strain of avian HEV and the pathogenic avian HEV strain in laying hens of 30 weeks of age; (2).Identification of genetic determinants for HEV attenuation by using avian HEV infectious cDNA clone and chickens as a model; and (3).Understanding the roles of the small ORF3 protein in HEV replication and/or pathogenesis. This will be accomplished by using standard techniques including animal experiments, cell cultures, PCR, cloning and sequencing, mutagenesis, molecular biology, biochemical, virological, serological and pathological methods. Continuing support of this project will enable us to fully utilize the precious reagents and tools generated from the past funding period to launch more in-depth studies on the structural and functional relationship of HEV genes using a unique small homologous animal model. The data from this study will help design effective preventive and control measures against this important human pathogen. The lack of knowledge on HEV basic biology and pathogenesis has greatly hindered the development of a vaccine against HEV. The information gained from this project will help understand the mechanisms of HEV replication and pathogenesis, and help devise effective preventive and control strategies against this important but extremely understudied human pathogen.

描述（由申请人提供）：戊型肝炎病毒（HEV）是人类戊型肝炎的病原体，是许多发展中国家的重要公共卫生问题，也是美国和其他工业化国家的流行病。据报道，受感染孕妇的死亡率高达30%。由于缺乏实用的动物模型和足够的体外细胞培养系统，人们对HEV的复制机制和发病机制知之甚少，目前还没有针对HEV的疫苗。在一项为期4年的R01奖的支持下，我们已经获得了大量的重要数据，包括构建了一种禽HEV病毒株的感染性cDNA克隆，以及建立了一种独特的小型同源HEV鸡模型。由于我们已经完成了所有建议的工作，并且由于这个为期4年的R01于2006年6月14日结束（目前处于1年的无费用延长期），我们因此提交了这个经过两次修订的竞争性更新（A2），以继续我们对这一重要但研究极为不足的人类病原体的长期目标。中心假设是禽HEV和鸡是描述HEV复制和发病机制的有用模型系统。长期目标是通过以禽HEV和鸡为模型系统，并利用禽HEV感染性cDNA克隆鉴定对这些过程具有重要功能的HEV基因和遗传决定因素，确定HEV复制和发病机制。在这个两次修改的竞争性更新中，有三个具体目标：(1)。30周龄蛋鸡非致病性禽戊型肝炎病毒株与致病性禽戊型肝炎病毒株发病机理的比较（2）.利用禽HEV感染性cDNA克隆和鸡模型鉴定HEV衰减的遗传决定因素和(3)。了解小ORF3蛋白在HEV复制和/或发病机制中的作用。这将通过使用标准技术来完成，包括动物实验、细胞培养、PCR、克隆和测序、诱变、分子生物学、生化、病毒学、血清学和病理学方法。该项目的持续支持将使我们能够充分利用过去资助期产生的宝贵试剂和工具，利用独特的小型同源动物模型对HEV基因的结构和功能关系进行更深入的研究。这项研究的数据将有助于设计有效的预防和控制措施，以防止这一重要的人类病原体。